Skip to main content
SpringerLink
Log in

Medikamentöse Versorgung von Demenzpatienten als Teil einer integrativen „Teamproduktion“ — Diskussion von Verschreibungs- und Behandlungsverhalten und gesundheitspolitische Handlungsempfehlungen

Medical care for dementia sufferers as part of an integrative “team production” — Discussion of prescription and treatment patterns and recommended course of action from a health policy perspective

  • Übersichtsartikel
  • Published:
PharmacoEconomics German Research Articles

Abstract

The number of older individuals with dementia will increase over the next years. Thus, there is an ongoing debate over how to face the challenges of financing their medical care and how to identify appropriate pharmacotherapies. Some empirical articles have elaborated on problems of inappropriate quality of care for patients suffering from dementia. They identified quality deficits due to missing information, qualifications and cooperation structures as well as the potentially negative impact of budget restraints that confront physicians. From an economic point of view taken in this paper, it seems necessary to analyse the problem as a case of “team production”. The conclusion indicates that enhancing cooperative structures for medical production is paramount and that all strategies building on cooperative behaviour need to be accompanied with well-defined means for financing the challenges of an aging society. Hence, “risk sharing” between social institutions and private savings is necessary and must be conveyed by political strategies that are aware of the impact of the ongoing aging process within all industrialised countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Kooperation und Verantwortung. Voraussetzungen einer zielorientierten Gesundheitsversorgung. Bonn: 2007

  2. BMFSFJ. Vierter Bericht zur Lage der älteren Generation in der Bundesrepublik Deutschland: Risiken, Lebensqualität und Versorgung Hochaltriger — unter besonderer Berücksichtigung demenzieller Erkrankungen. Berlin: BMFSFJ, 2002

    Google Scholar 

  3. Melchinger H. Chronische Versorgungsdefizite. Deutsches Ärzteblatt 2007; 104: 3236–3237

    Google Scholar 

  4. Online-Befragung zur Versorgung von Demenzpatienten. Data on file, Janssen-Cilag GmbH, Neuss: 2007

  5. Bickel H. Stand der Epidemiologie. In: Hallauer JF, Kurz A (Hrsg.). Weiβbuch Demenz. Stuttgart: Thieme Verlag, 2002: 10–14

    Google Scholar 

  6. Hallauer JF. Epidemiologie für Deutschland mit Prognose. In: Hallauer JF, Kurz A (Hrsg.). Weiβbuch Demenz. Stuttgart: Thieme Verlag, 2002: 15–17

    Google Scholar 

  7. Hallauer JF, Berger K, Ruckdäschel S. Nationale und internationale Untersuchungsergebnisse. In: Hallauer JF, Kurz A (Hrsg.). Weiβbuch Demenz. Stuttgart: Thieme Verlag, 2002: 20–23

    Google Scholar 

  8. Rychlik R. Gutachten über die Unterversorgung mit Arzneimitteln in Deutschland für den Verband Forschender Arzneimittelherzsteller e. V., Institut für Empirische Gesundheitsökonomie. Burscheid: 2007.

    Google Scholar 

  9. Black SE, Doody R, Li H et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology 2007; 69: 459–469

    Article  PubMed  CAS  Google Scholar 

  10. Cummings JL, McRae T, Zhang R. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatr 2006; 14: 605–612

    Article  Google Scholar 

  11. Demling J, Kornhuber J. Stand der Pharmakotherapie. In: Hallauer JF, Kurz A (Hrsg.). Weiβbuch Demenz. Stuttgart: Thieme Verlag, 2002: 40–47

    Google Scholar 

  12. IQWiG. Cholinesterasehemmer bei Alzheimer Demenz, Abschlussbericht A05-19A, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (Hrsg.). Köln: 2007

  13. Burns A, O’Brien J. Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology 2006; 20: 732–755

    Article  PubMed  CAS  Google Scholar 

  14. McRae T, Knopman D, Duttagupta S, Ieni J, Provenzano G. Donepezil delays time to nursing home placement. Journal of the American Geriatrics Society 2001; 49: S132–S132

    Google Scholar 

  15. Feldman H, Kavanagh S, Brashear HR et al. Effect of Galantamine on time to residential or nursing home admission. 2004 Poster presented at the 8th European Federation of Neurological Societies

  16. Cahill S, Clark M, O’Connell H et al. The attidues and practices of general practitioners regarding dementia diagnosis in Ireland. International Journal of Geriatric Psychiatry 2008; veröffentlicht bevor Druck. Online erhältlich.

  17. Cahill S, Clark M, O’Connell H et al. Dementia in primary care: the first survey of Irish general practitioners. International Journal of Geriatric Psychiatry 2006; 21: 319–324

    Article  PubMed  Google Scholar 

  18. Turner S, Iliffe S, Downs M et al. General practitioners’ knowledge, confidence and attitudes in the diagnosis and management of dementia. Age and Ageing 2004; 33: 461–467

    Article  PubMed  Google Scholar 

  19. Maeck L, Haak S, Knoblauch A et al. Early diagnosis of dementia in primary care: a representative eight-year follow-up study in Lower Saxony, Germany. International Journal of Geriatric Psychiatry 2007; 22: 23–31

    Article  PubMed  Google Scholar 

  20. Ingenhag W. Voraussetzungen aus Sicht der Gesetzlichen Krankenversicherung. In: Hallauer JF, Kurz A (Hrsg.). Weiβbuch Demenz. Stuttgart: Thieme Verlag, 2002: 123–126

    Google Scholar 

  21. Breyer F, Zweifel P, Kifmann M. Gesundheitsökonomik. Heidelberg: Springer-Verlag, 2005

    Google Scholar 

  22. Hamann J, Adjan S, Leucht S et al. Psychiatric decision making in the adoption of a new antipsychotic in Germany. Psychiatric Services 2006; 57: 700–703

    Article  PubMed  Google Scholar 

  23. Lundin D. Moral hazard in physician prescription behavior. Journal of Health Economics 2000; 19: 639–662

    Article  PubMed  CAS  Google Scholar 

  24. Dusheiko M, Gravelle H, Yu N et al. The impact of budgets for gatekeeping physicians on patient satisfaction: Evidence from fundholding. Journal of Health Economics 2007; 26: 742–762

    Article  PubMed  Google Scholar 

  25. Stoppe G, Pirk O, Haupt M. Treatment of Alzheimer’s disease utilising the best available evidence-based medicine — Utopia? Gesundheitswesen 2005; 67: 20–26

    Article  PubMed  CAS  Google Scholar 

  26. Peikert P. Richtgröβen und Richtgröβenprüfungen nach dem ABAG. Medizinrecht 2003; 21: 29–34

    Article  Google Scholar 

  27. Schmid K. Richtgröβenregress — was nun? Deutsches Ärzteblatt 2007; 104: 3210–3212

    Google Scholar 

  28. Erlei M, Leschke M, Sauerland M. Neue Institutionenökonomik, 2. Auflage. Stuttgart: Schäffer-Poeschel, 2007

    Google Scholar 

  29. Holmstrom B. Moral Hazard and Observability. Bell Journal of Economics 1979; 10: 74–91

    Article  Google Scholar 

  30. Macho-Stadler I, Pérez-Castrillo D. An Introduction to the Economics of Information, Incentives and Contracts. Oxford: Oxford University Press, 2001

    Google Scholar 

  31. Wolfs CAG, Dirksen CD, Severens JL et al. The added value of a multidisciplinary approach in diagnosing dementia: a review. International Journal of Geriatric Psychiatry 2006; 21: 223–232

    Article  PubMed  Google Scholar 

  32. Brayne C, Fox C, Boustani M. Dementia screening in primary care — Is it time? JAMA 2007; 298: 2409–2411

    Article  PubMed  CAS  Google Scholar 

  33. Salzman C. Medication compliance in the elderly. Journal of Clinical Psychiatry 1995; 56: 18–23

    PubMed  Google Scholar 

  34. Brodaty H, Green A. Defining the role of the caregiver in Alzheimer’s disease treatment. Drugs & Aging 2002; 19: 891–898

    Article  Google Scholar 

  35. Callahan CM, Boustani MA, Unverzagt FW et al. Effectiveness of Collaborative Care for Older Adults With Alzheimer Disease in Primary Care: A Randomized Controlled Trial. JAMA 2006; 295: 2148–2157

    Article  PubMed  CAS  Google Scholar 

  36. Vickrey BG, Mittman BS, Connor KI et al. The effect of a disease management intervention on quality and outcomes of dementia care — A randomized, controlled trial. Annals of Internal Medicine 2006; 145: 713–726

    PubMed  Google Scholar 

  37. Dietz B. Die Pflegeversicherung — Ansprüche, Wirklichkeiten und Zukunft einer Sozialreform. München: Oldenburg Verlag, 2002

    Book  Google Scholar 

  38. Ritter P, Hohmeier J. Alterspolitik. Eine sozio-ökonomische Perspektive. München: Oldenburg Verlag, 1999

    Google Scholar 

  39. Bartels S, Levine K, Shea D. Community-Based Long-Term Care for older Persons with severe and persistent Mental Illness in an Era of Managed Care. Psychiatric Services 1999; 50: 1189–1197

    PubMed  CAS  Google Scholar 

  40. Williamson OE. Comparative Economic Organization: The Analysis of Discrete Structural Alternatives. Administrative Science Quarterly 1991; 36: 269–296

    Article  Google Scholar 

  41. Langa K, Larson E, Wallace R et al. Out-of-Pocket Health Care Expenditures among older Americans with Dementia. Alzheimer Disease & Associated Disorders 2004; 18: 90–98

    Article  Google Scholar 

  42. Skuban R. Pflegeversicherung in Europa. Sozialpolitik im Binnenmarkt. Wiesbaden: Verlag für Sozialwissenschaften, 2004

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Forschungsstelle für Sozialrecht und Gesundheitsökonomie, Universität Bayreuth, 95440, Bayreuth, Deutschland

    Jürgen Zerth

  2. Janssen-Cilag GmbH, Neuss, Deutschland

    Maren Gaudig

  3. Forschungsstelle für Sozialrecht und Gesundheitsökonomie, Universität Bayreuth, Bayreuth, Deutschland

    Andreas Schmid

Authors
  1. Jürgen Zerth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maren Gaudig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jürgen Zerth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zerth, J., Gaudig, M. & Schmid, A. Medikamentöse Versorgung von Demenzpatienten als Teil einer integrativen „Teamproduktion“ — Diskussion von Verschreibungs- und Behandlungsverhalten und gesundheitspolitische Handlungsempfehlungen. Pharmacoeconomics-Ger-Res-Articles 6, 53–68 (2008). https://doi.org/10.1007/BF03320751

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03320751

Search

Navigation